Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
JAMA Network Open, 7(5), e2413172
If hunger or weight gain returns, the dose may need adjustment rather than complete discontinuation
Both medication classes are recommended by NICE for use in type 2 diabetes when first-line treatments prove insufficient, though they differ significantly in their administration routes, potency, and additional clinical benefits
They were first developed for the treatment of Type 2 Diabetes but over time it was found these medications also promoted weight loss
Tirzepatide, the active ingredient behind the popular weight loss drug Zepbound and the diabetes drug Mounjaro, has more tricks up its sleeve
US$ 22.76
US$ 22.37
US$ 25.98
US$ 26.62
